Georgia vs Malta: HIV-positive TB patients on ART (antiretroviral therapy)
Georgia
100.0%
in 2024
Malta
100.0%
in 2023
Georgia rank
1st
Malta rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Georgia
- Malta
How they compare
Georgia currently reports 100.0% against 100.0% in Malta, a difference of 0.0%.
Across all 8 years both countries report, Malta has been ahead every year.
Georgia ranks 1st and Malta ranks 1st of 144 countries.
Malta has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Georgia | Malta | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 68.0% | 100.0% | 32.0% | Malta |
| 2010s | 89.0% | 100.0% | 11.0% | Malta |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Georgia or Malta?
- Georgia, at 100.0% against 100.0% in Malta as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Georgia and Malta?
- 0.0%, with Georgia ahead.
- How many years of comparable data are there for Georgia and Malta?
- 8 years are reported by both, from 2006 to 2023.
- How do Georgia and Malta rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Georgia ranks 1st and Malta ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.